ES2182061T3 - 1 - (2 - desoxi - 2 - fluor-4- tio-beta-d arabinofuranosil)citosina. - Google Patents
1 - (2 - desoxi - 2 - fluor-4- tio-beta-d arabinofuranosil)citosina.Info
- Publication number
- ES2182061T3 ES2182061T3 ES97916633T ES97916633T ES2182061T3 ES 2182061 T3 ES2182061 T3 ES 2182061T3 ES 97916633 T ES97916633 T ES 97916633T ES 97916633 T ES97916633 T ES 97916633T ES 2182061 T3 ES2182061 T3 ES 2182061T3
- Authority
- ES
- Spain
- Prior art keywords
- citosine
- desoxi
- arabinofuranosil
- fluor
- tio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11196896 | 1996-04-09 | ||
| JP21508296 | 1996-07-26 | ||
| JP27863196 | 1996-09-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2182061T3 true ES2182061T3 (es) | 2003-03-01 |
Family
ID=27312140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97916633T Expired - Lifetime ES2182061T3 (es) | 1996-04-09 | 1997-04-09 | 1 - (2 - desoxi - 2 - fluor-4- tio-beta-d arabinofuranosil)citosina. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6147058A (enExample) |
| EP (1) | EP0841344B1 (enExample) |
| JP (1) | JP3657008B2 (enExample) |
| AT (1) | ATE224909T1 (enExample) |
| CA (1) | CA2224155C (enExample) |
| DE (1) | DE69715774T2 (enExample) |
| DK (1) | DK0841344T3 (enExample) |
| ES (1) | ES2182061T3 (enExample) |
| PT (1) | PT841344E (enExample) |
| WO (1) | WO1997038001A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7138384B1 (en) | 1997-08-29 | 2006-11-21 | The Regents Of The University Of California | Modulators of DNA cytosine-5 methyltransferase and methods for use thereof |
| US6348587B1 (en) * | 1998-02-25 | 2002-02-19 | Emory University | 2′-Fluoronucleosides |
| WO2005027962A1 (en) * | 2003-09-18 | 2005-03-31 | Isis Pharmaceuticals, Inc. | 4’-thionucleosides and oligomeric compounds |
| US7524831B2 (en) * | 2005-03-02 | 2009-04-28 | Schering Corporation | Treatments for Flaviviridae virus infection |
| EP2388257A1 (en) * | 2010-05-20 | 2011-11-23 | LibraMedicina, Inc. | Process for preparing substituted 1-O-acyl-2-deoxy-2-fluoro-4-thio-ß-D-arabinofuranoses |
| US8329925B2 (en) * | 2009-12-18 | 2012-12-11 | Libramedicina, Inc. | Process for preparing substituted 1-O-acyl-2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranoses |
| EP2832740B1 (en) * | 2012-03-28 | 2019-04-24 | FUJIFILM Corporation | SALT OF 1-(2-DEOXY-2-FLUORO-4-THIO-beta-D-ARABINOFURANOSYL)CYTOSINE |
| CN104540803B (zh) | 2012-08-13 | 2018-04-24 | 富士胶片株式会社 | 1-(2-脱氧-2-氟-4-硫代-β-D-阿拉伯呋喃糖基)胞嘧啶的合成中间体和硫代核苷的合成中间体以及它们的制造方法 |
| US10005779B2 (en) | 2013-06-05 | 2018-06-26 | Idenix Pharmaceuticals Llc | 1′,4′-thio nucleosides for the treatment of HCV |
| CN106061959B (zh) * | 2014-02-18 | 2018-11-09 | 富士胶片株式会社 | 四氢噻吩骨架型糖化合物的制造方法及四氢噻吩骨架型糖化合物 |
| JP6351107B2 (ja) * | 2014-02-18 | 2018-07-04 | 富士フイルム株式会社 | チオラン骨格型糖化合物の製造方法およびチオラン骨格型糖化合物 |
| JP6204223B2 (ja) | 2014-02-19 | 2017-09-27 | 富士フイルム株式会社 | チオピラノース化合物等の製造方法 |
| TWI678373B (zh) | 2014-10-31 | 2019-12-01 | 日商富士軟片股份有限公司 | 硫代核苷衍生物或其鹽及醫藥組合物 |
| EP3279207B1 (en) * | 2015-04-03 | 2024-01-24 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Novel compound of 4'-thionucleoside, as well as preparation method therefor, pharmaceutical composition thereof and application thereof |
| JP6450356B2 (ja) * | 2016-02-29 | 2019-01-09 | 富士フイルム株式会社 | 液状医薬製剤 |
| JP7008025B2 (ja) | 2016-08-31 | 2022-01-25 | 富士フイルム株式会社 | 抗腫瘍剤、抗腫瘍効果増強剤及び抗腫瘍用キット |
| AU2017383598B2 (en) | 2016-12-22 | 2021-06-03 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Solid form of 4'-thio-2'-fluoronucleoside phosphamide compound and preparation method therefor and use thereof |
| EP3677267A4 (en) * | 2017-09-01 | 2021-06-02 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF TUMORS, METHOD AND USES THEREOF |
| WO2019146130A1 (ja) * | 2018-01-29 | 2019-08-01 | 富士フイルム株式会社 | 胆道がん用抗腫瘍剤および胆道がんの処置方法 |
| WO2019146129A1 (ja) * | 2018-01-29 | 2019-08-01 | 富士フイルム株式会社 | イソクエン酸デヒドロゲナーゼ変異を有する腫瘍に対する医薬組成物および抗腫瘍剤ならびにその利用 |
| TW202000207A (zh) * | 2018-02-26 | 2020-01-01 | 日商富士軟片股份有限公司 | 膀胱癌用抗腫瘤劑及膀胱癌的處置方法 |
| CA3093794C (en) * | 2018-03-13 | 2023-03-14 | Fujifilm Corporation | Antitumor enhancer agent comprising 1-(2-deoxy-2-fluoro-4-thio-b-d-arabinofuranosyl)cytosine and an antitumor platinum complex |
| WO2020068657A1 (en) * | 2018-09-25 | 2020-04-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | 2'-halogenated-4'-thio-2'-deoxy-5-azacytidine analogs and use thereof |
| WO2020108343A1 (zh) * | 2018-11-28 | 2020-06-04 | 四川科伦博泰生物医药股份有限公司 | 以4'-硫代核苷类化合物为活性成分的口服药物组合物、其制备方法及其用途 |
| KR20220039748A (ko) * | 2019-07-30 | 2022-03-29 | 주식회사 피노바이오 | 암 치료용 디뉴클레오티드 화합물 및 그의 의약 용도 |
| KR20240028451A (ko) | 2021-07-29 | 2024-03-05 | 후지필름 가부시키가이샤 | Bap1 및 pbrm1 중 적어도 하나의 기능 저하를 갖는 종양에 대한 의약 조성물 및 항종양제 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE74701B1 (en) * | 1989-10-04 | 1997-07-30 | Univ Birmingham | Further antiviral pyrimidine nucleosides |
| WO1996001834A1 (en) * | 1994-07-12 | 1996-01-25 | Yamasa Corporation | 2'-deoxy-2'-(substituted or unsubstituted methylidene)-4'-thionucleoside |
| JPH0853490A (ja) * | 1994-08-09 | 1996-02-27 | Yamasa Shoyu Co Ltd | ２’−デオキシ−２’，２’−ジハロゲノ−４’−チオヌクレオシド |
-
1997
- 1997-04-09 AT AT97916633T patent/ATE224909T1/de active
- 1997-04-09 US US08/973,529 patent/US6147058A/en not_active Expired - Lifetime
- 1997-04-09 DE DE69715774T patent/DE69715774T2/de not_active Expired - Lifetime
- 1997-04-09 EP EP97916633A patent/EP0841344B1/en not_active Expired - Lifetime
- 1997-04-09 CA CA002224155A patent/CA2224155C/en not_active Expired - Lifetime
- 1997-04-09 JP JP52839997A patent/JP3657008B2/ja not_active Expired - Lifetime
- 1997-04-09 ES ES97916633T patent/ES2182061T3/es not_active Expired - Lifetime
- 1997-04-09 DK DK97916633T patent/DK0841344T3/da active
- 1997-04-09 PT PT97916633T patent/PT841344E/pt unknown
- 1997-04-09 WO PCT/JP1997/001206 patent/WO1997038001A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0841344A1 (en) | 1998-05-13 |
| JP3657008B2 (ja) | 2005-06-08 |
| CA2224155C (en) | 2004-10-26 |
| WO1997038001A1 (en) | 1997-10-16 |
| DE69715774D1 (de) | 2002-10-31 |
| ATE224909T1 (de) | 2002-10-15 |
| EP0841344B1 (en) | 2002-09-25 |
| PT841344E (pt) | 2003-02-28 |
| CA2224155A1 (en) | 1997-10-16 |
| EP0841344A4 (enExample) | 1998-05-13 |
| US6147058A (en) | 2000-11-14 |
| DK0841344T3 (da) | 2002-12-23 |
| DE69715774T2 (de) | 2003-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2182061T3 (es) | 1 - (2 - desoxi - 2 - fluor-4- tio-beta-d arabinofuranosil)citosina. | |
| ECSP034460A (es) | Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos | |
| MX9204111A (es) | Triazoles substituidos y procedimiento para su obtencion. | |
| ES2159919T3 (es) | Procedimiento para la preparacion de compuestos de tipo ceramidas. | |
| ES2053778T3 (es) | Procedimiento para la obtencion de derivados del tiazol. | |
| SE8505011D0 (sv) | Production of aminoethylethanolamine using rare earth metal or strontium hydrogen phosphates as catalysts | |
| ES2051843T3 (es) | Un proceso para la preparacion de un derivado del acido benzoilaminofenoxibutanico. | |
| ES2064371T3 (es) | Procedimiento enzimatico para la produccion de cianhidrinas opticamente activas. | |
| ES2130312T3 (es) | Nuevos derivados de tetrazina con actividad acaricida. | |
| AR006058A1 (es) | Procedimientos para preparar compuestos de dicianoacetato y de 1,2-pirazol-5-amino-3-substituido | |
| ES2164700T3 (es) | Procedimiento para preparar carbinoles de aril-piperidina. | |
| ES8706700A1 (es) | Procedimiento para preparar un derivado de cefalosporina. | |
| ES2069281T3 (es) | Derivado de fenantreno. | |
| ES2032752T3 (es) | Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina. | |
| ES2060127T3 (es) | Halogenoalquilfenil-alcoholes-cetonas y sus hidratos. | |
| SE9604582D0 (sv) | Novel compounds | |
| ES2043738T3 (es) | Procedimiento para la reduccion de cetonas. | |
| ATE40340T1 (de) | Verfahren zur hydrierung eines alkylierten anthrachinons. | |
| AR248029A1 (es) | Un procedimiento para la preparacion de n-fosfonometilglicina. | |
| AR240813A2 (es) | N-fenilsulfonil-n'-pirimidinilureas, procedimiento para su preparacion, composiciones que las contienen e intermediarios para uso exclusivo en dicho procedimiento | |
| TR199800210T2 (xx) | Didepsipeptid temelli endoparazitisid kompozisyonlar, yeni didepsipeptidler ve bunlar�n �retimi i�in i�lemler. | |
| ES2106480T3 (es) | Un compuesto perteneciente a la familia de los analogos de la 15-deoxi-espergualina, su procedimiento de preparacion y su utilizacion en terapeutica. | |
| ES2090731T3 (es) | Preparacion de derivados insaturados del acido carbamico. | |
| HUP9801925A1 (hu) | Nátrium/hidrogén-csere inhibítorok alkalmazása protozoák által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására | |
| ES2052672T3 (es) | Derivados de los acidos (6-(hetero)ariloxi-naftalin-2-il-oxi)-alcanocarboxilicos. |